Cargando…

Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review

INTRODUCTION: Although previously regarded as a children’s disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD...

Descripción completa

Detalles Bibliográficos
Autores principales: Fasseeh, Ahmad N., Elezbawy, Baher, Korra, Nada, Tannira, Mohamed, Dalle, Hala, Aderian, Sandrine, Abaza, Sherif, Kaló, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674816/
https://www.ncbi.nlm.nih.gov/pubmed/36197589
http://dx.doi.org/10.1007/s13555-022-00819-6
_version_ 1784833231750692864
author Fasseeh, Ahmad N.
Elezbawy, Baher
Korra, Nada
Tannira, Mohamed
Dalle, Hala
Aderian, Sandrine
Abaza, Sherif
Kaló, Zoltán
author_facet Fasseeh, Ahmad N.
Elezbawy, Baher
Korra, Nada
Tannira, Mohamed
Dalle, Hala
Aderian, Sandrine
Abaza, Sherif
Kaló, Zoltán
author_sort Fasseeh, Ahmad N.
collection PubMed
description INTRODUCTION: Although previously regarded as a children’s disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD burden is significant due to its substantial humanistic burden and psychosocial effects. This study aims to summarize and quantify the clinical, economic, and humanistic burden of AD in adults and adolescents. METHODS: A systematic literature search was performed in PubMed, Scopus, Cochrane, Centre for Reviews and Dissemination (CRD), EconPapers, The Professional Society for Health Economics and Outcomes Research (ISPOR), The National Institute for Health and Care Excellence (NICE), and The Canadian Agency for Drugs and Technologies in Health (CADTH). Studies were included if they reported clinical, economic, or humanistic effects of AD on adults or adolescents, from January 2011 to December 2020. The Grading of Recommendations Assessment tool was used to assess risk of bias for the included studies. Regression models were used to explain the correlation between factors such as disease severity and quality of life (QoL). RESULTS: Among 3400 identified records, 233 studies were included. Itch, depression, sleep disturbance, and anxiety were the most frequently reported parameters related to the clinical and humanistic burden of AD. The average utility value in studies not stratifying patients by severity was 0.779. The average direct cost of AD was 4411 USD, while the average indirect cost was 9068 USD annually. CONCLUSIONS: The burden of AD is significant. The hidden disease burden is reflected in its high indirect costs and the psychological effect on QoL. The magnitude of the burden is affected by the severity level. The main limitation of this study is the heterogeneity of different studies in terms of data reporting, which led to the exclusion of potentially relevant data points from the summary statistics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13555-022-00819-6.
format Online
Article
Text
id pubmed-9674816
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-96748162022-11-20 Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review Fasseeh, Ahmad N. Elezbawy, Baher Korra, Nada Tannira, Mohamed Dalle, Hala Aderian, Sandrine Abaza, Sherif Kaló, Zoltán Dermatol Ther (Heidelb) Review INTRODUCTION: Although previously regarded as a children’s disease, it is clear that atopic dermatitis (AD) is also highly prevalent in adults. Because AD is not associated with mortality, it is usually neglected compared with other, fatal diseases. However, several studies have highlighted that AD burden is significant due to its substantial humanistic burden and psychosocial effects. This study aims to summarize and quantify the clinical, economic, and humanistic burden of AD in adults and adolescents. METHODS: A systematic literature search was performed in PubMed, Scopus, Cochrane, Centre for Reviews and Dissemination (CRD), EconPapers, The Professional Society for Health Economics and Outcomes Research (ISPOR), The National Institute for Health and Care Excellence (NICE), and The Canadian Agency for Drugs and Technologies in Health (CADTH). Studies were included if they reported clinical, economic, or humanistic effects of AD on adults or adolescents, from January 2011 to December 2020. The Grading of Recommendations Assessment tool was used to assess risk of bias for the included studies. Regression models were used to explain the correlation between factors such as disease severity and quality of life (QoL). RESULTS: Among 3400 identified records, 233 studies were included. Itch, depression, sleep disturbance, and anxiety were the most frequently reported parameters related to the clinical and humanistic burden of AD. The average utility value in studies not stratifying patients by severity was 0.779. The average direct cost of AD was 4411 USD, while the average indirect cost was 9068 USD annually. CONCLUSIONS: The burden of AD is significant. The hidden disease burden is reflected in its high indirect costs and the psychological effect on QoL. The magnitude of the burden is affected by the severity level. The main limitation of this study is the heterogeneity of different studies in terms of data reporting, which led to the exclusion of potentially relevant data points from the summary statistics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13555-022-00819-6. Springer Healthcare 2022-10-05 /pmc/articles/PMC9674816/ /pubmed/36197589 http://dx.doi.org/10.1007/s13555-022-00819-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Review
Fasseeh, Ahmad N.
Elezbawy, Baher
Korra, Nada
Tannira, Mohamed
Dalle, Hala
Aderian, Sandrine
Abaza, Sherif
Kaló, Zoltán
Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
title Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
title_full Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
title_fullStr Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
title_full_unstemmed Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
title_short Burden of Atopic Dermatitis in Adults and Adolescents: a Systematic Literature Review
title_sort burden of atopic dermatitis in adults and adolescents: a systematic literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674816/
https://www.ncbi.nlm.nih.gov/pubmed/36197589
http://dx.doi.org/10.1007/s13555-022-00819-6
work_keys_str_mv AT fasseehahmadn burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview
AT elezbawybaher burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview
AT korranada burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview
AT tanniramohamed burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview
AT dallehala burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview
AT aderiansandrine burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview
AT abazasherif burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview
AT kalozoltan burdenofatopicdermatitisinadultsandadolescentsasystematicliteraturereview